| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/01/2009 | EP2040533A2 Improved yield and stress tolerance in transgenic plants |
| 04/01/2009 | EP1880006B1 Primate t-lymphotropic viruses |
| 04/01/2009 | EP1827081A4 Stress tolerance in plants through selective inhibition of trehalose-6-phosphate phosphatase |
| 04/01/2009 | EP1629098B1 Complement inhibitors from ticks |
| 04/01/2009 | EP1597379B1 Endomannosidases in the modification of glycoproteins in eukaryotes |
| 04/01/2009 | EP1585984B1 Diagnostic methods for protein profiling |
| 04/01/2009 | EP1549341B1 Tissue factor targeted antibodies as anticoagulants |
| 04/01/2009 | EP1539967B1 Expression cassettes for expressing nucleic acid sequences in sink tissues of plants that store carbohydrate |
| 04/01/2009 | EP1532248B1 Modified small interfering rna molecules and methods of use |
| 04/01/2009 | EP1472375B1 Gene products differentially expressed in cancerous breast cells and their methods of use |
| 04/01/2009 | EP1467720B1 Dna dosage forms |
| 04/01/2009 | EP1456239B1 Hybrid proteins with neuregulin heparin-binding domain for targeting to heparan sulfate proteoglycans |
| 04/01/2009 | EP1446425B1 Treatment of micro-organism infection |
| 04/01/2009 | EP1427825B1 Cdna encoding the human alpha2 delta4 calcium channel subunit |
| 04/01/2009 | EP1349873B1 Modulation of il-2- and il-15-mediated t cell responses |
| 04/01/2009 | EP1312671B1 Magnetic particles having lower limit critical solution temperature |
| 04/01/2009 | EP1301794B1 Method for quantification of akt protein expression |
| 04/01/2009 | EP1292613B9 Chimeric GPF-Aequorin as bioluminiscent Ca++ reporters at the single cell level |
| 04/01/2009 | EP1153139B1 Polymorphic markers of the lsr gene |
| 04/01/2009 | EP1131087B2 Alleviatation of prostate cancer symptoms |
| 04/01/2009 | EP1119623B1 Mage-a3 peptides presented by hla class ii molecules |
| 04/01/2009 | EP1100873B1 Cancer cells from body fluids containing cells, isolation thereof and agents containing the same |
| 04/01/2009 | EP1053350B1 Methods for dna amplification and sequencing |
| 04/01/2009 | EP1029067B1 Nucleic acid molecules which encode proteins having fructosyl transferase activity and methods for producing long-chain inulin |
| 04/01/2009 | EP0970207B1 Heregulin variants |
| 04/01/2009 | EP0805856B2 Animal feed additives comprising xylanase |
| 04/01/2009 | CN101400806A Method for detection of mutant gene |
| 04/01/2009 | CN101400802A A quantitative method for HBV-DNA, a primer and probe for detecting HBV-DNA, and a detecting kit comprising the same |
| 04/01/2009 | CN101400799A Process for the production of beta-lysine |
| 04/01/2009 | CN101400798A Preparation of polyunsaturated fatty acids |
| 04/01/2009 | CN101400797A Method of selection and regeneration of transgenic brassica jxmcea on xylose |
| 04/01/2009 | CN101400796A System for the expression of orthogonal translation components in eubacterial host cells |
| 04/01/2009 | CN101400795A Chimeric tymovirus-like particles |
| 04/01/2009 | CN101400794A Nucleotide sequences and corresponding polypeptides conferring improved nitrogen use efficiency characteristics in plants |
| 04/01/2009 | CN101400793A Novel cancer-associated antigen |
| 04/01/2009 | CN101400792A New nucleic acid molecules and collections thereof, their application and identification |
| 04/01/2009 | CN101400791A De-differentiation of astrocytes into neural stem cell using NANOG |
| 04/01/2009 | CN101400790A Peptide for inhibition of influenza infection, inhibitor of influenza infection, liposome, and prophylactic/therapeutic agent for influenza |
| 04/01/2009 | CN101400789A Novel beta-galactoside alpha- 2,6-sialyltransferase, gene coding for the transferase and process for producing the same |
| 04/01/2009 | CN101400703A Domain antibody construct |
| 04/01/2009 | CN101397583A SCAR mark detection technique for breeding improved variety of tilapia |
| 04/01/2009 | CN101397574A Flavivirus NS1 subunit vaccine |
| 04/01/2009 | CN101397573A Retroviral vector for expression of glial cell line-derived neurotrophic factor and use thereof |
| 04/01/2009 | CN101397572A Method for rescuing influenza virus and bidirectional transcription vector special therefor |
| 04/01/2009 | CN101397571A Preparation of double promoter DNA anti-caries vaccine pCN-SSIE |
| 04/01/2009 | CN101397570A Intermediate vector for gene targeting, preparation method and use thereof |
| 04/01/2009 | CN101397569A Method for improving tobacco virus resistance |
| 04/01/2009 | CN101397568A Bacteria ferulic acid decarboxylase gene and crystal structure thereof |
| 04/01/2009 | CN101397567A Novel expression, renaturation of recombinant snake venom metalloproteinase and its biology activity |
| 04/01/2009 | CN101397566A Superoxide dismutase and coding gene thereof |
| 04/01/2009 | CN101397565A Rice high affinity nitrate transport protein gene OsNAR2.1 |
| 04/01/2009 | CN101397564A Protection against environmental toxicity through manipulation of the processing of messenger RNA precursors |
| 04/01/2009 | CN101397563A T2r taste receptors and genes encoding same |
| 04/01/2009 | CN101397562A Construction method for major histocompatibility complex/peptide tetramer for chicken and products thereof |
| 04/01/2009 | CN101397561A N-glycosylated genetic engineering modified yeast pichia |
| 04/01/2009 | CN101397560A Method for producing human tumor necrosis factor-alpha |
| 04/01/2009 | CN101397559A Method for increasing abundance and stability of antibacterial peptide expressed inside plant |
| 04/01/2009 | CN101397558A Clone, expression and use of schistosoma japonicum membrane protein gene TSP2 |
| 04/01/2009 | CN101397557A Method for preparing streptavidin marked phycoerythrocyanins fluorescence protein |
| 04/01/2009 | CN101397556A Method for preparing streptavidin marked phycoerythrocyanins fluorescence protein |
| 04/01/2009 | CN101397555A Method for preparing streptavidin marked allophycocyanins fluorescence protein |
| 04/01/2009 | CN101397554A Method for preparing streptavidin marked phycoerythrocyanins alpha subunit type fluorescence protein |
| 04/01/2009 | CN101397553A Glucose isomerase mutant |
| 04/01/2009 | CN101397552A High efficiency recombinant expressed chitoanase |
| 04/01/2009 | CN101397551A Neukinase and its use in treatment of cardiovascular disease |
| 04/01/2009 | CN101397550A Mutant firefly luciferase |
| 04/01/2009 | CN101397549A Aryl hydrocarbon hydroxylase system and use |
| 04/01/2009 | CN101397548A Recombinant corynebacterium crematum by expression of vitreoscilla haemoglobin gene and use thereof |
| 04/01/2009 | CN101397547A Method for constructing klebsiella with deleted capsula |
| 04/01/2009 | CN101397343A VEGF receptor fusion protein and its use in preparation of medicament for treating eye disease |
| 04/01/2009 | CN101397342A Anti-schistosoma japonicum monoclonal antibody NP11-4 chimeric Fab antibody, preparation method and use |
| 04/01/2009 | CN101397338A Detection method for protein activity of fish growth hormone |
| 04/01/2009 | CN101397337A Neuroregulation protein mutant and uses thereof |
| 04/01/2009 | CN101397336A Antigenic Neisserial peptides |
| 04/01/2009 | CN100473729C Kit for detecting chlamydia trachomatis |
| 04/01/2009 | CN100473728C Nucleic acid molecules for detecting bacteria and phylogenetic units of bacteria |
| 04/01/2009 | CN100473725C Bacillus thuringiensis Cry ET 33 and Cry ET 34 compositions and uses therefor |
| 04/01/2009 | CN100473724C Novel VIP3 toxins and methods of use |
| 04/01/2009 | CN100473723C Amplifying repetitive nucleic acid sequences |
| 04/01/2009 | CN100473721C Pneumovirus NS proteins antagonising interferon (IFN) response |
| 04/01/2009 | CN100473665C H5 subtype avian flu virus hemagglutinin protein monoclonal antibody, and preparing method and use thereof |
| 04/01/2009 | CN100473664C Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof |
| 04/01/2009 | CN100473663C Heterologous expression of neisserial proteins |
| 04/01/2009 | CN100473662C Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 03/31/2009 | US7511199 Inbred corn line BB14 |
| 03/31/2009 | US7511198 Transformed maize plant comprising in its genome at least one stably incorporated heterologous nucleic acid molecule comprising a DNA insert; modulating phytate and increasing phosphorus levels; nutritional feeds and foods; gene expression inhibition |
| 03/31/2009 | US7511197 Garden bean cultivar H26108 |
| 03/31/2009 | US7511196 Soybean variety XB57E07 |
| 03/31/2009 | US7511195 Soybean variety XB54V07 |
| 03/31/2009 | US7511194 Soybean variety XB25E07 |
| 03/31/2009 | US7511193 Soybean variety XB15E07 |
| 03/31/2009 | US7511192 Soybean variety XB15B07 |
| 03/31/2009 | US7511191 Raffinose synthase genes and their use |
| 03/31/2009 | US7511190 Expressing a polypeptide encoded by a preferred polynucleotide sequence in a plant and detecting at least one factor that is modulated by or interacts with such polypeptide |
| 03/31/2009 | US7511189 Using vector transformation to generate seed with enhanced size/weight, carbon influx, fatty acid synthesis and oil content |
| 03/31/2009 | US7511188 Using vector transformation to generate crop plants coding fungicidal agents; disease resistant plants; biological pest control |
| 03/31/2009 | US7511132 Short interfering RNA sequences for use in the treatment and prevention of diabetes, alzheimer's and cancer; gene expression inhibition |
| 03/31/2009 | US7511131 Antisense modulation of apolipoprotein B expression |
| 03/31/2009 | US7511130 Chimeric rice Os-TubA-3 promoter and methods of use |
| 03/31/2009 | US7511129 Genetically engineered DNA transfer vector comprising a polynucleotide sequence that encodes a toxin comprising an insecticidal fragment |